Soricimed
Moncton
About Soricimed
Soricimed is a clinical-stage company with a focus on the development of targeted treatments for cancer. It specializes in developing delivery peptides and therapeutics for several types of solid tumor cancers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.3M
- Last round: Grant (Jul 2022)
- Website: soricimed.com
- Phone: 506-872-2181
Industries & Categories
Biopharma, Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/soricimed-16408 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.